About FluidForm Bio
FluidForm Bio is a company based in Waltham (United States) founded in 2017 by Michael Graffeo and Adam Feinberg. The company has 19 employees as of December 31, 2022. FluidForm Bio offers products and services including FRESH 3D Bioprinting. FluidForm Bio operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
- Headquarter Waltham, United States
- Employees 19 as on 31 Dec, 2022
- Founders Michael Graffeo, Adam Feinberg
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fluidform, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$228.55 K (USD), Grant
Aug 15, 2021
- Investors
-
Employee Count
19
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of FluidForm Bio
FluidForm Bio offers a comprehensive portfolio of products and services, including FRESH 3D Bioprinting.
Creates vascularized implantable tissues for medical treatments like diabetes.
People of FluidForm Bio
Unlock access to complete
Funding Insights of FluidForm Bio
Investors in FluidForm Bio
FluidForm Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for FluidForm Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by FluidForm Bio
Investment portfolio details for FluidForm Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - FluidForm Bio
Detailed financials for FluidForm Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fluidform Bio Comparisons
Peer comparison for FluidForm Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of FluidForm Bio
FluidForm Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of renewable products for industrial solutions
|
|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
Detailed competitors of FluidForm Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fluidform Bio
Complete news archive for FluidForm Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FluidForm Bio
FluidForm Bio was founded in 2017 and raised its 1st funding round 4 years after it was founded.
FluidForm Bio is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Michael Graffeo is the current CEO of FluidForm Bio. They have also founded this company.
As of Dec 31, 2022, the latest employee count at FluidForm Bio is 19.
FluidForm Bio was founded in 2017 and is based in Waltham, United States. 3D bioprinting solutions for engineered tissues are developed by the company within the biotechnology sector. FRESH technology is integrated with 3D printing, computational biology, synthetic biology, artificial intelligence, and advanced materials. Tissues are constructed using cells and proteins for applications in research and medical fields.
FluidForm Bio offers FRESH 3D Bioprinting.
FluidForm Bio has 1 investor. Key investors include HHS.